What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/1822/31743 |
Resumo: | Bacterial infections are a global health concern with high levels of mortality and morbidity associated. The resistance of pathogens to drugs is one leading cause of this problem, being common the administration of multiple drugs to improve the therapeutic effects. This review critically explores diverse aspects involved in the treatment of bacterial infections through multi-drug therapies, from a mathematical and within-host perspectives. Five recent models were selected and are reviewed. These models fall into the following question: which drugs to select, the respective dose, the administration period to effectively eradicate the infection in the shortest period of time and with reduced side effects? In this analysis, three groups of variables were considered: pharmacokinetics, pharmacodynamics and disturbance variables. To date, there is no model that fully answers to this issue for a living organism and it is questionable whether this would be possible for any case of infection. |
id |
RCAP_9615164b692be0c100b15a5e24b2f049 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/31743 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective?InfectionsMulti-drug therapyDrug interactionsResistancePK/PD modelsScience & TechnologyBacterial infections are a global health concern with high levels of mortality and morbidity associated. The resistance of pathogens to drugs is one leading cause of this problem, being common the administration of multiple drugs to improve the therapeutic effects. This review critically explores diverse aspects involved in the treatment of bacterial infections through multi-drug therapies, from a mathematical and within-host perspectives. Five recent models were selected and are reviewed. These models fall into the following question: which drugs to select, the respective dose, the administration period to effectively eradicate the infection in the shortest period of time and with reduced side effects? In this analysis, three groups of variables were considered: pharmacokinetics, pharmacodynamics and disturbance variables. To date, there is no model that fully answers to this issue for a living organism and it is questionable whether this would be possible for any case of infection.COST -European Cooperation in Science and Technology(287514)ElsevierUniversidade do MinhoPimenta, FranciscoAbreu, Ana CristinaSimões, Lúcia C.Simões, M.20142014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/31743engPimenta, Francisco; Abreu, Ana Cristina; Simões, L.C.; Simões, Manuel What should be considered in the treatment of bacterial infections by multi-drug therapies: A mathematical perspective? Drug Resistance Updates 17(3) 51-63, 2014.1368-76461532-208410.1016/j.drup.2014.08.00125156320info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:25:15Zoai:repositorium.sdum.uminho.pt:1822/31743Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:19:28.473397Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
title |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
spellingShingle |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? Pimenta, Francisco Infections Multi-drug therapy Drug interactions Resistance PK/PD models Science & Technology |
title_short |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
title_full |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
title_fullStr |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
title_full_unstemmed |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
title_sort |
What should be considered in the treatment of bacterial infections by multi-drug therapies: a mathematical perspective? |
author |
Pimenta, Francisco |
author_facet |
Pimenta, Francisco Abreu, Ana Cristina Simões, Lúcia C. Simões, M. |
author_role |
author |
author2 |
Abreu, Ana Cristina Simões, Lúcia C. Simões, M. |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Pimenta, Francisco Abreu, Ana Cristina Simões, Lúcia C. Simões, M. |
dc.subject.por.fl_str_mv |
Infections Multi-drug therapy Drug interactions Resistance PK/PD models Science & Technology |
topic |
Infections Multi-drug therapy Drug interactions Resistance PK/PD models Science & Technology |
description |
Bacterial infections are a global health concern with high levels of mortality and morbidity associated. The resistance of pathogens to drugs is one leading cause of this problem, being common the administration of multiple drugs to improve the therapeutic effects. This review critically explores diverse aspects involved in the treatment of bacterial infections through multi-drug therapies, from a mathematical and within-host perspectives. Five recent models were selected and are reviewed. These models fall into the following question: which drugs to select, the respective dose, the administration period to effectively eradicate the infection in the shortest period of time and with reduced side effects? In this analysis, three groups of variables were considered: pharmacokinetics, pharmacodynamics and disturbance variables. To date, there is no model that fully answers to this issue for a living organism and it is questionable whether this would be possible for any case of infection. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014 2014-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/1822/31743 |
url |
http://hdl.handle.net/1822/31743 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pimenta, Francisco; Abreu, Ana Cristina; Simões, L.C.; Simões, Manuel What should be considered in the treatment of bacterial infections by multi-drug therapies: A mathematical perspective? Drug Resistance Updates 17(3) 51-63, 2014. 1368-7646 1532-2084 10.1016/j.drup.2014.08.001 25156320 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132653666959360 |